InvestorsHub Logo
Followers 58
Posts 10175
Boards Moderated 1
Alias Born 09/21/2016

Re: F1ash post# 148016

Wednesday, 04/18/2018 8:20:30 AM

Wednesday, April 18, 2018 8:20:30 AM

Post# of 463580
Juvenile Toxicology: Relevance and Challenges for Toxicologists and Pathologists



https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670269/#!po=21.1111

Time is a big issue for most of us here I assume. Doing this kind of profile before any Rett as a prerequisite to RETT trial involving kids. So,....we'll wait.

BTW, after the last few days of angst it is beginning to look to me like Dr.M. has his OWN clock. Thanks to folks going to this session, asking questions and providing some insights so..... we now have a clue. M knows he has the right stuff. He knows it works and is about to demonstrate how to write history....his way, on his clock and according to his priorities. The various regulatory bodies are getting it or have got it by now. If they are smart they will put his stuff at the head of the line. It all makes sense now. We can agonize all we want about what he should be doing according to some abstract model of our construct. He has the goods, he is working with the people he needs to work with, he will decide what the best sequence of events is and he will execute according to that model. People like me should just watch and enjoy. AD is the big one but they(CNS diseases) are all important. As the process of elimination goes forward, eventually, science will develop to treat most.

It all makes sense now. All the rest of us have to do is pray for those kids and patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News